Get the Weekly Intelligence Brief — top committee picks every Sunday.

MET vs TRU

MetLife Inc. vs TransUnion — AI-powered side-by-side comparison
MET
MetLife Inc.
56
Buy
VS
TRU
TransUnion
63
Buy
MetricMETTRU
AI Score 56 63
Price $95.89 $85.01
P/E Ratio 18.26× 22.20×
ROE 11.9% 10.3%
Revenue Growth YoY
Gross Margin 25.6% 55.8%
Debt / Equity 0.74× 1.17×
Dividend Yield 2.4% 0.6%
RSI (14) 50.1 68.6
Beta 0.763 1.53
Expected Upside +1.7%

AI Committee View

Current Innellis committee reasoning for MET versus TRU.
TRU leads by 7 points.

TRU scores 63/100 (Buy) versus MET at 56/100 (Buy).

MET Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — current ratio of 0.19 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Dividend yield of 3.3% pays you to wait — Value
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • EPS declining -11.0% YoY despite any revenue growth — Growth
  • MACD histogram negative -- bearish momentum — Technical
  • Current ratio of 0.19 is tight -- limited short-term liquidity cushion — Risk
TRU Committee View
75% agreement
4 analysts

The primary driver is price structure making higher highs and higher lows. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MET Full Analysis TRU Full Analysis